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Abstract 
Background: The small ruminant parasite Haemonchus contortus is the most widely used parasitic 
nematode in drug discovery, vaccine development and anthelmintic resistance research. Its 
remarkable propensity to develop resistance threatens the viability of the sheep industry in many 
regions of the world and provides a cautionary example of the effect of mass drug administration to 
control parasitic nematodes. Its phylogenetic position makes it particularly well placed for 
comparison with the free-living nematode Caenorhabditis elegans and the most economically 
important parasites of livestock, as well as the human hookworms.  
Results: Here we report the detailed analysis of a draft genome assembly and extensive 
transcriptomic dataset for H. contortus. This represents the first genome to be published for a 
strongylid nematode and the most extensive transcriptomic dataset for any parasitic nematode 
reported to date. We show a general pattern of conservation of genome structure and gene content 
between H. contortus and C. elegans, but also a dramatic expansion of important parasite gene 
families. We identify genes involved in parasite-specific pathways such as blood feeding, 
neurological function, and drug metabolism. In particular, we describe complete gene repertoires for 
known drug target families, providing the most comprehensive understanding yet of the action of 
several important anthelmintics. Also, we identify a set of genes enriched in the parasitic stages of 
the lifecycle and the parasite gut that provide a rich source of vaccine and drug target candidates.   
Conclusions: The H. contortus genome and transcriptome provides an essential platform for post-
genomic research in this and other important strongylid parasites. 
Keywords  
nematode, parasite, anthelmintic, resistance, genome, transcriptome 
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Background 
Resistance to broad spectrum anthelmintic drugs is now widespread in parasites of domestic 
livestock [1, 2] and there are increasing concerns about the sustainability of human parasite control 
programmes using mass administration of the same drugs [3]. Consequently, there is an urgent need 
to understand the genetic mechanisms underlying anthelmintic resistance and to discover new 
methods of chemical and non-chemical control. However, the genomic and genetic resources 
required to underpin research in parasitic nematodes are lacking [4-6]. The free-living nematode 
Caenorhabditis elegans is a powerful model system, but it has clear limitations for the study of 
parasitic species [7]. Although the need to develop workable parasitic nematode model systems is 
widely recognised, most human helminth species are not amenable to experimental study. In 
contrast, Haemonchus contortus, a gastrointestinal parasitic nematode of small ruminants, has a 
successful track record in anthelmintic resistance [7, 8], drug discovery [9, 10] and vaccine [11-13] 
research. It is amongst the most experimentally tractable parasites for a number of reasons: adult 
females are relatively large and produce thousands of eggs per day allowing the production of large 
amounts of biological and genetic material, the infective larvae (L3) can be viably cryopreserved, and 
in vivo studies, including genetic crosses, can be undertaken in the natural host [8]. Its phylogenetic 
position within the most closely-related group of parasites to C. elegans facilitates comparative 
genomics and heterologous gene expression allowing functional studies to be performed on H. 
contortus genes and regulatory elements [4, 14]. As it is a strongylid nematode, research on this 
parasite is of particular relevance to the most economically significant parasites of grazing ruminants 
and to the human hookworms [15]. H. contortus itself causes major economic loss in small 
ruminants worldwide; it is highly pathogenic and unsurpassed in its ability to develop resistance to 
every anthelmintic used in its control. Notably, these include a number of core drugs used for mass 
drug administration programmes in humans [3]. Anthelmintic resistance in H. contortus and related 
strongylids now threaten the viability of the sheep industry throughout the world [2]. This 
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represents both a warning and a useful model for the consequences of the widespread intensive use 
of anthelmintics that are now being used to control human parasites in the developing world [3].  
H. contortus has a direct and rapid lifecycle (Figure S1 in Additional file 1); adults reside and mate in 
the abomasum of the ruminant host, then females produce eggs to be excreted in the faeces. The 
eggs embryonate, develop and hatch as first stage larvae (L1), develop and moult to become second 
stage larvae (L2), then moult again to become third stage larvae (L3) in the faeces. The L3 migrate 
onto pasture to be ingested by the grazing ruminant host. The L3 shed the retained L2 cuticle 
(exsheath) in the rumen, travel to the abomasum and develop through to the fourth larval stage (L4) 
then adults in two to three weeks [16]. As voracious blood-feeders, H. contortus L4 and adults can 
cause severe haemorrhagic gastritis, hypoproteinaemia, anaemia and oedema, with acute infections 
resulting in death of the animal host. One adult female can produce up to 10,000 eggs per day [17] 
and a single animal can harbour thousands of worms. This extremely high fecundity, under 
conducive host and environmental conditions, can give rise to population explosions and devastating 
disease outbreaks. Development occurs most rapidly in warm humid conditions, but the L4 stage can 
undergo arrested development within the host to survive adverse conditions such as prolonged 
drought or cold winters [18]. This feature of facultative arrested development, aided by movement 
of domestic livestock and climate change, has ensured the worldwide distribution and success of this 
parasite even though its evolutionary origins were in sub-Saharan Africa [19].  
One striking feature of H. contortus, in common with related nematode species, is the extremely 
high level of genetic diversity that has been reported in both laboratory and field populations; this is 
thought to be predominantly a function of its large effective population size [20-22]. Genetic 
variation may underlie both the parasite’s remarkable ability to adapt to different climatic regions 
and host species [23] and its alarming propensity to develop drug resistance. This high level of 
genetic polymorphism has also provided a major challenge to genome assembly necessitating the 
production of an inbred line from which to prepare DNA template.  
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In this paper, we describe the assembly and annotation of the draft genome of MHco3(ISE).N1, a 
genetically well characterised inbred H. contortus strain that is susceptible to all major anthelmintic 
drugs. The most extensive comparative transcriptomic sequencing and analysis yet described for a 
parasitic nematode was undertaken on representative life-stages and the nematode gut to explore 
different aspects of nematode biology, evolution and parasitism. This draft genome provides a 
platform for future research in anthelmintic resistance, drug discovery and vaccine development 
using H. contortus, currently the most important experimental model for the strongylid nematode 
group.  
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Results and Discussion 
Genome structure and content 
We assembled a draft sequence of the H. contortus genome based on data from a mixture of 
sequencing technologies (see Material and Methods, and Supplementary results and methods in 
Additional file 1). Our final draft assembly consists of 67,687 contigs linked into 26,044 scaffolds of 
total length 370 Mb, including 23.8 Mb of inferred gaps between contigs, with an average and N50 
scaffold length of 14,206 and 83,287 bp respectively (Table S1 in Additional file 1). This is a 
significantly larger genome size than the ~60Mb predicted with flow cytometry [24] but it is 
consistent with a prediction of ~200-300Mb inferred from a pilot annotation of two large contiguous 
regions of the genome [14], making this the largest nematode genome sequenced to date (Table S1 
in Additional file 1). The overall base composition of all sequence contigs was close to neutral at a 
mean 41.3% GC, slightly higher than that for other clade V nematodes. Approximately 93% of 
conserved eukaryotic genes can be identified in the assembly, suggesting that our draft assembly 
represents at least that fraction of the H. contortus genome [25], as many of these models are 
incomplete or split between contigs (Table S2 in Additional file 1). Despite this, our current assembly 
is of similar quality to some other published draft nematode genome sequences [26-30] (Table S1 in 
Additional file 1). 
We used extensive transcriptomic evidence from across the H. contortus life cycle (see Methods and 
Table S3 in Additional file 1) to guide de-novo gene model curation for protein-coding genes. We 
predict a similar number of protein-coding genes to the C. elegans genome (21,799 vs. 20,532), but 
significantly lower gene density of 59 genes per Mb, with only seven percent of the genome being 
protein coding, compared to 200 genes per Mb and a protein coding content of ~30% in the C. 
elegans genome (Figure 1). The average coding sequence length is similar in H. contortus and C. 
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elegans (1127 bp in H. contortus compared to 1371 bp in C. elegans) but the average gene length is 
more than double in the parasite (6564 bp compared to 3010 bp in C. elegans).  A closer look at a 
subset of 2822 H. contortus and C. elegans one-to-one orthologs shows the discrepancy is explained 
by an expansion in both the number and length of introns in H. contortus (average of ten introns per 
gene, average size 633 bp; relative to six introns per gene, average size 340 bp in C. elegans). An 
expansion in intronic sequence has also been reported in the closely related necromenic nematode 
Pristionchus pacificus but to a less dramatic extent (average of nine introns per gene, average size 
309 bp) [26]. Over 80% of H. contortus and C. elegans one-to-one orthologs present on the same 
scaffold occur on the same C. elegans chromosome (Table S4 in Additional file 1), suggesting 
widespread conservation of synteny between the two species (Figure 2). However, gene order is 
generally poorly conserved, which is consistent with comparisons between C. elegans and related 
nematodes [27, 31], but regions of conserved microsynteny are apparent and may prove useful in 
supporting orthology of divergent genes. 
Reflecting this relatively expanded genome, approximately 29% of the draft genome assembly 
consists of repetitive sequence (compared to ~16% in C. elegans) including 2434 copies of the 
characteristic HcRep element previously reported from a number of trichostrongylid species [14, 32-
34]. The repetitive sequence also includes representatives of many known repeat families in other 
nematodes, with approximately 6% of the genome derived from LINEs, 2.5% from long terminal 
repeat retrotransposons and 5% from DNA transposons, including TTAA-specific, Mariner-like and 
MuDR-superfamily elements, together with evidence of elements related to Tc1 and Tc4 of C. 
elegans. Despite belonging to similar families, H. contortus repeats represent independent 
expansions to those in other clade V nematodes, as repeat libraries from H. contortus show little 
similarity to genome sequence from other species, and vice-versa. Our transcriptomic data suggests 
that active transposition is occurring, with evidence of expression for four out of 26 gene models 
annotated with transposase domains and 49 out of 482 reverse transcriptase domain-containing 
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proteins. Expressed proteins appear to belong to a range of DNA transposon types, and to Gypsy-
related and LINE retro-elements. 
In C. elegans, around 17% of genes are in operons [35]: tightly linked clusters of two-to-eight genes, 
which are co-transcribed from the same promoter. The resulting polycistronic pre-mRNAs are 
resolved by trans-splicing with spliced leader (SL) SL1 and SL2 sequences. Most frequently, SL1 is 
trans-spliced to the first gene in an operon and downstream genes are SL2 trans-spliced. The 
structure (gene complement, order and orientation) of around 23% of C. elegans operons is 
conserved in the H. contortus genome. The structure of a further 10% of C. elegans operons appear 
to be partially conserved, where at least two orthologs are present on the same scaffold in the 
expected order and orientation, but one or more genes are in a different order, inverted or absent. 
Functional constraints are thought to conserve the intergenic distance in C. elegans operons to ~100 
bp but genes in H. contortus operons are further apart: the average intergenic distance of genes with 
a conserved operon structure is 992 bp (median 621 bp, largest 8329 bp), and the operon encoding 
ion channel subunits Hco-des-2H and Hco-deg-3H has an intergenic distance of 2342 bp [36].  
Overall, SL1 trans-splicing was detected in 6306 H. contortus genes and SL2 trans-splicing was 
detected in 578 genes. Of these, 318 trans-spliced genes were in the putative conserved operons 
identified above (see Additional methods in Additional file 1). All 126 first genes in operons were 
trans-spliced to SL1 (SL2 trans-splicing was detected in five putative first genes, but examination of 
their loci suggests they are downstream genes in new operons in this species); 119 downstream 
genes were trans-spliced to SL1 and 73 were trans-spliced to SL2. If SL2 trans-splicing is the 
definitive criterion in identifying operons, the relatively low level of SL2 trans-splicing to downstream 
genes suggests that either operon function is less frequently conserved than operon structure in H. 
contortus or that undetected, divergent SL2 sequences are present. However, the relatively high 
frequency of SL1 trans-splicing in genes that are also SL2 trans-spliced (~77%; 56 of 73 in conserved 
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operons, 445 of 578 in all genes identified) suggests SL1 trans-splicing of downstream genes may 
also be relatively common in this species. 
We employed two complementary approaches to global comparison of the H. contortus gene set, 
using the Inparanoid algorithm to look in detail at orthologs with C. elegans and Pristionchus 
pacificus, and OrthoMCL for a wider view of gene family evolution with other clade V nematodes. Of 
5,937 orthology groups between C. elegans and H. contortus, 5,012 are one-to-one orthologs, while 
an additional 899 orthologs could be identified in H. contortus and P. pacificus but not C. elegans, 
suggesting they have been lost in the C. elegans lineage (Table S5 in Additional file 1). A number of 
orthology groups are significantly expanded in H. contortus, including a family of 180 Haemonchus 
paralogs to a single C. elegans gene that lacks any functional annotation (Table S6 in Additional file 
1). Other expanded groups include genes with likely roles in parasitism, such as cysteine-rich 
secreted proteins, together with a set of helicase domains that include some with predicted signal 
peptides. Global analysis of the evolution of entire gene families (clusters of similar genes) across the 
clade V nematodes confirms this pattern of significant diversity within the clade (Figure 1), and 
allowed us to identify H. contortus genes lacking clear orthologs in other clade IV or V nematodes 
(Figure S2, Table S8 in additional file 1). This shows that the Haemonchus-specific proteome is 
enriched in genes encoding polypeptides involved in proteolysis, neurotransmission and 
carbohydrate metabolism, and in secreted proteins and those expressed in the cuticle. While some 
of these genes are explored in detail in the more focused analyses below, others may represent 
novel candidate genes involved in the host-parasite interface. 
Gene Expression in Parasite Life-stages and Gut 
As H. contortus progresses through its life cycle, it must adapt to different environments with 
differing food sources and energy requirements (see Figure S1 in Additional file 1) and this is 
reflected in differential gene expression. RNA-seq was used to analyse gene expression in six 
parasite life-stages and the adult female gut. Samples were made in triplicate from independent 
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batches of parasite material for every stage allowing statistically robust comparison of relative gene 
expression between the stages (see Methods and Table S3 in Additional file 1). We found significant 
expression for 17,483 genes in total from the six life stages studied; with between 13,962 (in L3) and 
15,569 (in adult males) genes expressed in each stage. A total of 11,295 genes were significantly up 
or down-regulated through the life-cycle (see Figure 3 and Materials and Methods) and we used 
annotation with Gene Ontology (GO) terms to investigate their broad functions. Metabolic enzyme 
expression throughout the parasite lifecycle was analysed in more detail and will be discussed 
separately.  
Genes up-regulated in the development from egg to the L1 stage include those associated with 
muscle development and motor activity, while up-regulated in the egg are genes associated with 
oxidoreductase activity, apoptosis, body morphogenesis and development, larval and embryo 
development, as well as DNA replication and chromosome organisation. This pattern is consistent 
with the progression from a developing embryonated egg to a motile and actively feeding larval 
stage.  
In the transition to the L3 stage, a decrease in the expression of genes associated with the myosin 
complex and motor activity and various metabolic processes are consistent with the nematode 
entering a quiescent state. Among the up-regulated genes there is an association with oxygen 
transport and heme binding. Oxidoreductase enzymes are over-represented and may reflect the 
increased need to detoxify a build up of endogenous waste, consistent with previous studies 
showing higher cytochrome P450 (CYP) activity in the H. contortus L3 than in L1 or adult stages [37]. 
CYPs have also been shown to be up-regulated in response to reduced food intake [38]. This is 
consistent with the significant increase in gluconeogenesis from the L1 to L3, which is also increased 
in the C. elegans dauer [39], and the up-regulation of acetyl-CoA metabolic process, likely to reflect 
metabolism of fat stores in the non-feeding L3. Genes associated with binding of cobalamin (Vitamin 
B12) are also up-regulated.  Cobalamin has been shown to be strongly concentrated and stored in 
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the infective L3 of other gastrointestinal nematodes [40] and a ready supply may be required for 
rapid larval development after ingestion by the host. 
The L4 is the first blood-feeding stage of H. contortus. The transition from the quiescent L3 stage to 
the motile L4 stage is reflected in significant up-regulation of many genes, including genes associated 
with motor activity, the myosin complex and locomotion as well as various metabolic processes. The 
binding of oxygen, lipids and sugars, possibly associated with active feeding, are also up-regulated as 
are changes in the expression of genes linked to response to oxidative stress that may reflect the 
reactivation of the parasite from its dormant stage. A significant increase in the expression of genes 
associated with collagen and cuticle development and body morphogenesis, consistent with parasite 
growth, is also observed. Interestingly, heme-binding genes were both up- and down-regulated, 
perhaps reflecting an increase in heme load from blood feeding and a decrease in CYP activity. 
Transition from the L4 to the adult stages is characterised by several changes. In the transition to the 
female stage, 1658 genes are up-regulated and correlate with gender-specific development as well 
as embryogenesis (adult females contain oocytes and eggs at various developmental stages), such as 
genitalia development, embryo development, oogenesis, ovulation, germ-line cell cycle switching, 
meiosis regulation and regulation of vulval development. A significant increase in DNA replication 
processes is also apparent. Between the L4 and adult male stage, lower expression in the adult male 
of genes linked with body morphogenesis, molting, collagen and cuticle development, 
oxidoreductase activity, heme binding and response to oxidative stress were observed among the 
various alterations in expression. Increased expression of genes annotated with the GO term 
‘structure molecule activity’ is due to up-regulation of a number of major sperm protein genes. 
These sex-specific gene expression patterns were confirmed by comparison between adult female 
and male parasites, and it is clear that many genes are highly enriched in male worms, being 
expressed only at low levels in other stages. The large set of genes highly expressed in both eggs and 
adult females were again apparent. 
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Finally, we investigated gene expression in the H. contortus intestine, the major organ of digestion 
and detoxification in the nematode, by comparing the female gut sample with the whole female 
worm. Consistent with data from H. contortus gut EST libraries [41], increased expression of genes 
with protein kinase, cysteine-type peptidase and cysteine-type peptidase inhibitor activities 
predominated. Genes associated with sugar and cobalamin binding were significantly up-regulated 
as were genes associated with transport of cations, anions and oligopeptides. Oxidoreductase 
activity was also increased, consistent with the expression pattern of detoxification genes in C. 
elegans [42].  
 
Metabolic Pathways and Chokepoint Analysis 
Comparisons between H. contortus and the free-living nematodes revealed 22 enzyme classifications 
(ECs) that were restricted to the parasite (Table S9 in Additional file 1). While more detailed analysis 
is required, metabolism of amino acids and carbohydrates clearly differ between these two groups. 
For example, lysine 6-aminotransferase (EC 2.6.1.36) catalyses lysine to glutamate, which can be 
further converted to α-ketoglutarate, an intermediate of the tricarboxylic acid (TCA) cycle. Lysine 6-
aminotransferase was previously considered restricted to prokaryotes, thus its activity in H. 
contortus needs to be confirmed. 
A summary of up- and down-regulated metabolic enzymes across all life-stages is shown in Table S10 
(in Additional file 1). The transition through eggs, L1, L3 and L4, showed a striking pattern: from L1 to 
L3, most enzyme classifications were down-regulated, including those involved in carbohydrate, lipid 
and energy metabolism, but many of these are up-regulated again in the transition to L4. This is 
consistent with the L3 being a stage in which development is arrested analogous to the dauer larva 
in C. elegans. Further support for this comparison is the up-regulation of two enzymes that 
independently convert isocitrate to 2-oxo-glutarate, while most other parts of the TCA cycle are 
down-regulated. Furthermore, 2-oxo-glutarate is an entry metabolite into the ascorbate and 
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aldarate metabolic pathway, which is implicated in increased lifespan in Drosophila [43]. The L4-to-
male transition shows a decrease in lipid metabolism coupled with an increase in amino acid 
metabolism.  
Metabolic chokepoints – reactions that uniquely consume or produce a metabolite – are enzymes 
that seem likely to be essential to the parasite and so may be potential targets for future drug 
development. Analysis of the H. contortus network revealed 362 chokepoint reactions, five of which 
passed additional criteria of lacking isoenzymes and being divergent from known human enzymes 
[44] (see Table S11 in Additional file 1). Comparison of these against the Therapeutic Target 
Database (TDD) revealed that two are known potential targets for anthelmintic drugs: trehalose-6-
phosphatase (EC 3.1.3.12) is a member of the sucrose metabolism pathway, and is currently being 
researched as a potential drug target in the filarial nematode B. malayi [45], while dTDP-4-
dehydrorhamnose 3,5-epimerase (EC 5.1.3.13) is currently of interest in Mycobacterium tuberculosis 
[46]. This validation of the approach justifies further analysis of the other three chokepoint enzymes 
identified.  
Neuromuscular Drug Targets  
In nematodes, the pentameric ligand-gated ion-channel (pLGIC) family is particularly numerous, with 
64 members identified in H. contortus via homology with Caenorhabditis spp., P. pacificus and RNA-
seq data (Figure 4). They are of great importance in parasitic nematodes because they are targets of 
the majority of the currently available anthelmintic drugs (as summarized in Table S12 in Additional 
file 1; the β-tubulin targets of the benzimidazole group have been described previously [47]).  
The pLGICs regulate the flow of anions, typically chloride ions, or cations, including sodium and 
calcium, in response to an extracellular signal in the form of an activating ligand or change in pH. 
They are fundamental to synaptic transmission; interference with their normal function results in 
paralysis and death. Drugs that activate the anionic channels, such as the macrocyclic lactone 
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ivermectin (IVM), typically inhibit neuronal transmission and muscle contraction. Those that activate 
the cationic channels, such as levamisole (LEV) and monepantal, stimulate neuronal transmission 
and typically induce muscle contraction. Here we present the most complete picture of these 
channels to date and show that as expected, this parasite is very similar to C. elegans and supports 
the use of the free-living worm as a functional model for the parasite nervous system. There are 
however some important differences, most significantly in glutamate signaling that is sensitive to the 
macrocyclic lactones and acetylcholine signaling that sensitive to levamisole, as well as characteristic 
loss of some receptor genes associated with biogenic amine signaling. 
The macrocyclic lactones, which include IVM and moxidectin, act at several different glutamate-
gated chloride channels. Some of these are found in both C. elegans and H. contortus, but it is 
noteworthy that two H. contortus subunit genes, glc-5 and glc-6, encode glutamate sensitive 
channels that are absent from C. elegans. It is likely these were lost from the rhabtidid lineage as 
homologous sequences can be detected in the genome of the close relative P. pacificus. Both of 
these subunits are targets for the macrocyclic lactones [48, 49] and changes in either their sequence 
or expression have been associated with drug resistance in veterinary parasites [50]. The archetypal 
target of IVM, Cel-glc-1, appears to be a duplication of avr-15, specific to C. elegans. These 
differences may explain the difficulties encountered in understanding ivermectin’s mode of action 
and resistance in parasitic nematodes by studying the model organism [51]. Most of the other 
anionic channel subunits in H. contortus have direct orthologs in C. elegans (Figure 4A). The only 
notable absences are lgc-48 and lgc-54. lgc-48 encodes an as yet uncharacterized member of the 
acc-1 acetylcholine gated chloride channels [52] that appears to have been lost from H. contortus, 
and lgc-54 encodes an uncharacterized member of the C. elegans biogenic amine-gated chloride 
channel family that may not be present in H. contortus [53].  
The acetylcholine gated receptor (AChR) cation channels are of particular interest as they are the 
targets of several anthelmintic drugs already in use (levamisole, monepantel and derquantel) and 
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are considered to be one of most promising gene families for the identification of new drug targets.  
Comparison of the H. contortus gene family with those found in C. elegans is shown in Figure 4B. 
There is a one-to-one correspondence in H. contortus for subunits of the acr-16 clade [54], named 
for the homomeric nicotine sensitive channel in C. elegans, and acr-16 expression is much higher in 
adult males than in other life-stages, as previously described for C. elegans [55]. The anthelmintic 
levamisole targets receptors composed of α subunits of the unc-38 clade and non-α subunits from 
the unc-29 clade. In C. elegans three different alpha and two different non-alpha subunits combine 
to form a channel that responds to acetylcholine, strongly to levamisole and only weakly to nicotine 
[56]. The α-type acr-13 (lev-8) gene, required in C. elegans for the LEV receptor, appears to have 
been lost in H. contortus as an ortholog of this gene is detectable in P. pacificus. The non-alpha gene 
lev-1 is present, but the signal peptide appears to have been lost [57]. A LEV receptor in H. contortus 
can be reconstituted without either of these, requiring only UNC-38, UNC-63 and UNC-29 as in C. 
elegans [57] and replacing ACR-13 with ACR-8.  Most strikingly, the non-α subunit gene unc-29 in C. 
elegans corresponds to four paralogous copies in H. contortus [57]. A LEV sensitive channel has been 
reconstituted containing the Hco-UNC-29.1 subunit [58]. The degree to which the other copies may 
have diverged in function is currently under investigation.  The deg-3 clade [54] encodes subunits 
that form channels involved in chemotaxis, and is of particular interest as channels encoded by des-
2/deg-3 and acr-23 in C. elegans are targeted by the relatively new anthelmintic monepantel (MPTL), 
with acr-23 as the principle target of MPTL action in vivo [9]. The single subunit gene mptl-1 in H. 
contortus corresponds to the acr-23/acr-20 pair in C. elegans. Splice site mutations in the mptl-1 
gene are associated with resistance to MPTL [35], which would suggest that acr-23 is 
functionally equivalent to mptl-1.  
H. contortus possesses two AChR genes that are not present in C. elegans, acr-26 and acr-27, and 
these two genes seem to form a distinct clade, which suggests that they are likely to form receptors 
with a distinct pharmacology. Orthologs of acr-26 are found in many species of parasitic nematode 
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and therefore they might make interesting targets for the development of novel cholinergic 
anthelmintics. 
In summary, the majority of the pLGIC subunit genes in C. elegans have direct orthologs in H. 
contortus, although there is more variation in the repertoire of orphan family pLGICs (see Additional 
results, Additional file 1). This supports the use of C. elegans as a model to study the 
neuromusculature of H. contortus in drug screens, but there are important differences in specific 
anthelminthic targets: for each of the anthelmintics ivermectin, levamisole and monepantel, the 
drug targets in H. contortus are functionally different to the C. elegans model. 
Drug metabolism and efflux 
Parasitic nematodes are armed with a large repertoire of inducible metabolising enzymes and 
transporters to protect against environmental toxins. The nematode detoxification pathway can be 
divided into three main phases: modification, conjugation and excretion [59] involving the 
cytochrome P450s (CYPs) and the short-chain dehydrogenase/reductases (SDRs) in phase 1, the 
UDP-glucoronosyl transferases (UGTs) and the glutathione S-transferases (GSTs) in phase 2 and the 
ATP-binding cassette (ABC) transporters in phase 3. Little is known about the impact of the parasite 
detoxification system on anthelminthic efficacy or resistance [60], but a better understanding of 
these pathways will allow their role in anthelmintic resistance to be assessed and should also be 
informative in the design of new drugs and synergistic agents [61]. We have annotated a large 
number of modification and conjugation genes in the current assembly, identifying a total of 42 
CYPs, 44 SDRs, 34 UGTs and 28 GSTs (see Figure S5 in Additional file 1), but here we focus on the 
excretion transporters implicated in drug resistance.  
Members of the ATP Binding Cassette (ABC) transporter family hydrolyze ATP and couple the energy 
released with the active transport of a wide range of compounds including small organic molecules, 
lipids, proteins and metal ions. They are an essential component of many biological processes and 
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are fundamental to the barrier between a nematode and its environment. These transporters consist 
of a basic structure of six transmembrane (TM) domains with an associated intracellular ATP binding 
motif. The functioning transporter complex requires two of these protein halves, but some members 
of this family are fusion proteins with 12 TM domains and two ATP binding motifs. We find 
numerous differences in ABC transporter genes between C. elegans and H. contortus (Additional 
results and Figure S4, Additional file 1), with a reduced complement of haf-transporters including, 
for example, the loss of haf-6, which is essential for efficient RNAi in C. elegans [62], a significant 
expansion of ced-7, which has an unknown function in amphid and phasmid sensory cells and an 
extensive change in the repertoire of multidrug resistance protein genes. The P-glycoprotein (pgp) 
transporters are of particular interest as they have been implicated in resistance of H. contortus to 
ivermectin and other anthelmintics [49, 63], and this family has undergone significant change 
compared to the free living C. elegans. In total there are 10 P-glycoprotein genes identified in the H. 
contortus genome and this full complement will now allow a more systematic analysis of the role of 
P-glycoproteins in resistance to ivermectin and other anthelmintics. A cluster of four C. elegans 
genes, pgp-5, 6, 7 and 8, are not found in H. contortus. Cel-pgp-3 and 4 as well as Cel-pgp-12, 13 and 
14 represent gene duplication events corresponding to single genes in the parasite. Cel-pgp-9 
corresponds to two paralogous copies in H. contortus and in addition, two genes not present in C. 
elegans, related to pgp-3 and pgp-11, have been retained in H. contortus.  These are named pgp-16 
and pgp-17, respectively. Changes in the sequence or expression of pgp-1, pgp-2 and pgp-9 have 
been reported for ivermectin-resistant vs. susceptible isolates of H. contortus and in pgp-9 for 
resistant Telodorsagia circumcincta [50, 64, 65]. 
Protease vaccine candidates 
H. contortus is a voracious blood-feeder with even modest infections of 1000 worms generating losses 
of up to 50 ml blood per day [66]. Cysteine, aspartic and metallo-proteases as well as aminopeptidases 
have been implicated in important aspects of parasite function including haemoglobin digestion and 
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anticoagulant activity, and these enzymes are also important vaccine candidates. Vaccination with gut 
extracts enriched for these activities can confer up to 75% reduction in worm burden and 90% 
reduction in egg output [67]. Protection is thought to result from the ingestion of host antibodies by 
the parasite during blood-feeding, which bind to gut antigens and disrupt function. Female parasites 
appear to be more affected than males increasing the relative impact on egg output. Development of 
a commercial vaccine, however, requires identification and expression of specific proteases which, 
either singly or combined, induce protective immunity. Comparative genomics and transcriptome data 
can aid target selection by identifying potential functionally important proteases and those enriched 
in the gut of blood-feeding L4 and adult stages, suggesting a role in blood-feeding as well as 
accessibility to host antibodies.  
Cathepsin B protease (cbl) genes are part of an ordered haemoglobin degradation pathway, 
functioning after aspartic proteases (APR) and upstream of metalloproteases (MEP) and 
aminopeptidases [68, 69]. Cathepsin B diversity may therefore be key in generating an array of 
substrates from ingested nutrients for efficient cleavage by downstream proteases and may be 
involved in the high blood digestion capacity of H. contortus. Indeed, H. contortus has a higher copy 
number (63 genes) of cathepsin B protease (cbl) genes than related free-living nematodes, 
representing 80% of all cathepsin cysteine protease genes in the genome (Figure 5A). This large 
expansion of the cathepsin B family has resulted in H. contortus showing a greater diversity of cbl 
genes than known in any other parasitic nematode. Uniquely, members of each cbl type are 
arranged in tandem in the H. contortus genome (Figure 5B) and have the same genomic structure, 
suggesting that diversity has arisen through recent gene duplication. Reflecting this, most CBLs 
encoded in the H. contortus genome form large monophyletic groups distinct from C. elegans [70], 
hookworm [71] or other strongylid CBLs, suggesting that duplication and divergence has occurred 
separately following speciation. It is possible that gene amplification has occurred as a mechanism of 
increasing overall CBL expression associated with the need for H. contortus to digest the huge 
quantities of host blood it takes in during feeding. The cbl genes show increased expression in L4 and 
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adult stages and many are significantly enriched in gut tissue identifying these as potentially 
important control targets. These include both novel and previously identified cbl genes (AC-4, gcp-7 
and hmcp-2) [72-74], while other cbl transcripts are significantly up-regulated in the L4 stage and in 
adult male worms, but not in the gut, suggesting a role in development and reproduction rather 
than feeding. The CBLs identified here contain a putative N-terminal signal peptide and several have 
been identified in adult worm excretory-secretory (ES) products [75]. It has also been proposed that 
sequence variation of Hc-CBLs may confer antigenic diversity [76], and presentation to the host 
immune system through secretion may therefore drive the maintenance of the diversity of Hc-cbl 
genes. 3D modelling of the CBL repertoire and epitope mapping will clarify this issue. 
Other cathepsin cysteine protease genes are not expanded – for example, a cpr-6-like single copy 
gene is highly conserved in a number of parasitic and free-living nematodes, suggesting a house-
keeping role, and there is no expansion found for cathepsin L, F or Z genes in H. contortus. 
Furthermore, there is less expansion of genes encoding other vaccine candidates; H-gal-GP 
composed predominantly of pepsinogen-like aspartic and metallo proteases [77], and H11 
aminopeptidases [78]. These are integral gut membrane proteins, considered hidden from the 
immune system during natural infection [67] and lower diversity should be advantageous in 
vaccination studies. 
Significant expansion is, however, seen in the cathepsin aspartic protease family (Figure S6, 
Additional file 1). Importantly, the genome data identifies a novel, single-copy apr gene with 84% 
amino acid identity to APR-1 of the dog hookworm Ancylostoma caninum and which is significantly 
enriched in gut tissue. Vaccination with recombinant Ac-APR-1 significantly reduced faecal egg 
counts, worm burdens and anaemia [79], warranting investigation of the protective potential of the 
Haemonchus APR-1-related protease.  Other novel Hc-apr genes group phylogenetically with C. 
elegans asp genes (Figure S6 in Additional file 1) and are increased in the environmental L1 stage, 
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indicating a developmental role, consistent with C. elegans data [80, 81] and ruling these out as 
potential vaccine targets.  
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Conclusions 
Haemonchus contortus is the one of the most intensively researched parasitic nematode species and 
is the most established parasite species used in drug discovery, drug mode-of-action and drug 
resistance research. It is the first strongylid nematode to have its genome sequenced and the 
analysis presented here provides a first genomic insight into the biology of a gastro-intestinal 
strongylid and blood feeding parasitic nematode. It confirms the close relationship between H. 
contortus and C. elegans and provides a platform from which to apply the C. elegans biological 
knowledge to investigate the biology of this parasite for both basic and applied research. It also 
highlights specific differences between the species that will be important to inform researchers of 
those aspects of C. elegans biology that cannot be extrapolated. The genome sequence, gene 
models, transcriptome datasets and bioinformatic analyses provide a wealth of information on 
potential new drug and vaccine targets. They will also be an invaluable resource for the application 
of post-genomic technologies to this and other related strongylid parasites. 
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Materials and Methods  
Parasite material production and quality assurance 
The MHco3(ISE) line is a H. contortus strain, susceptible to all the major anthelmintic classes, that 
has been passaged in the laboratory by serial infection for many years. It has been extensively 
phenotypically and genetically characterised previously [82]. The inbred MHco3(ISE).N1 strain was 
derived by a genetically validated single pair mating of an adult male and an adult female 
MHco3(ISE) worm using a method of direct transplantation into the abomasum of a recipient 
parasite-free sheep (described in [83]).  The inbred MHco3(ISE).N1  strain was subsequently 
passaged by oral experimental infection of parasite-free sheep and parasite material was  harvested 
using standard methods (see Additional methods, Additional file 1 for details). All parasite material 
used in this study was derived from the inbred H. contortus MHco3(ISE).N1 strain except for the 
female gut transcriptomic data, which was generated from the MHco3(ISE)strain . The MHco3(ISE) 
and MHco3(ISE).N1 strains were routinely monitored for genetic  integrity at each passage, as was all 
parasite material derived from the strains, using a standard panel of microsatellite markers and a 
well established “genetic  fingerprinting” methodology [8, 82]. Both the MHco3(ISE) and the 
MHco3(ISE).N1 are viably cryopreserved and available on request.  
Genome sequencing and assembly 
We assembled a draft sequence of the H. contortus genome based on data from a mixture of 
sequencing technologies, including 21x coverage of paired-end and shotgun reads from a 
Roche454SLX platform and approximately 163x coverage of long- and short-insert paired-end 
libraries from an Illumina HiSeq (coverage based on a genome size of 370Mb). Genomic and 
transcriptomic sequence data was generated using largely standard molecular biology methods (see 
Additional methods, Additional file 1), except that whole-genome amplified material was used to 
generate sufficient material for a large-insert Illumina library from a single male worm, using a 
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modified protocol. The genomic reads from each technology were initially assembled independently 
using assembly algorithms most suited to the typical coverage and read length of each, and scaffolds 
from each were then merged to form an initial set of scaffolds that were then improved by 
automated gap filling, followed by breaking and re-scaffolding using the paired-end data from both 
sequencing platforms.  
Protein coding gene prediction and functional annotation 
After quality control and end-trimming, the transcriptome reads were mapped against the reference 
genome using TopHat software, v 2.0.6 (--mate-std-dev 50 -a 6 -i 10 -I 20000 --microexon-search --
min-segment-intron 10 --max-segment-intron 50000) [84]. A reference dataset of 399 H. contortus 
protein encoding genes was manually curated from predictions of highly conserved genes using 
CEGMA (version 2.4) [24] and RNA-seq mapping. 347 of those were used to train Augustus [85] and 
52 were used to independently evaluate the accuracy of the predictions. Final gene prediction (v2.0) 
was performed by Augustus using H. contortus specific parameters and RNA-seq, EST and polyA 
mappings as evidence hints generated by TopHat2 and PASA [86] respectively. Gene prediction 
accuracy was computed at the level of nucleotides, exons and complete genes on 57 manual curated 
gene models as described previously [87] and shown in table S7 (Additional file 1). Functional 
annotation information from the interpro databases using interproscan v4.5 [88], Gene Ontology 
(GO; [89]) terms were annotated via interpro2GO and from the curated C. elegans annotation in 
Wormbase (release 235;[90]) by assigning all GO terms shared by all C. elegans genes in a gene 
family to the H. contortus members of that family. Further functional insight was obtained by BLAST 
searches for similar genes in the GenBank nr database, and putative signal peptides were identified 
by SignalP [91]. To investigate H. contortus metabolism, a total of 828 enzyme classifications (ECs), 
covering 2,853 proteins, were assigned using KAAS [92], DETECT [93] and EFICAz [94]. Of these, 563 
ECs covering 1,246 proteins were assigned to a metabolic pathway; the others are non-metabolic 
enzymes. Similar annotation efforts were carried out on Caenorhabditis species and P. pacificus. 
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Gene expression and GO analysis 
The numbers of RNA-seq reads per gene model were counted using custom-made scripts making use 
of BEDtools and a gff file of the genome annotation, and based on the TopHat mapping described 
above. Analysis of gene expression was performed using the DESeq (v 1.8.1) package for 
Bioconductor [95]. Read coverage was normalised to estimate the effective library sizes for each 
library and negative binomial tests performed between pairs of sample triplicates, using dispersion 
estimates from the default approach, to obtain p-values for differential expression of each gene 
adjusted for false discovery rate using the Benjamini-Hochberg procedure for multi-testing [96]. Only 
genes with adjusted p-values less or equal to 1e
-5
 were retained.  GO terms enriched in the set of 
differentially expressed genes in each comparison were identified using the “weight01” algorithm of 
the TopGO (v 2.8.0) package for Bioconductor [97]. Only GO terms with p<0.01 were considered for 
more detailed analysis. Expression data was drawn using Circos-0.62. All differentially expressed 
genes were clustered using MBCluster.seq with 50 clusters, and clusters then ordered based on 
which stage had the highest mean expression in that cluster. 
Data access 
All sequences described in this paper have been submitted to the Genbank database, project ID 
PRJEB506. Sequence data is available at http://www.ncbi.nlm.nih.gov/nuccore/CAVP000000000 and 
annotation has been submitted to Genbank and Wormbase. 
The H. contortus genome assembly and functional annotation are available from 
ftp://www.sanger.ac.uk/pub/pathogens/Haemonchus/contortus. 
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Figure Legends 
Figure 1. Evolution of genome content in Clade V nematodes. A maximum-likelihood phylogeny 
based on concatenated alignment of single-copy genes. Values on edges represent the inferred 
numbers of births (+) and deaths (-) of gene families along that edge. Note that our approach cannot 
distinguish gene family losses from gains on the basal branches of this tree, so for example the value 
of 1263 gene family gains on the basal branch of clade V will include gene families lost on the branch 
leading to the clade IV spp. The first column of pie charts represent the gene family composition of 
each genome – the area of the circle is proportional to the predicted proteome size, and wedges 
represent the numbers of proteins predicted to be either singletons (i.e. not members of any gene 
family), members of gene families common to all nine genomes, members of gene families present 
only in a single genome, and members of all other gene families. The second column of pie charts 
represents the genomic composition of the species with published genome sequences. All ingroup 
nodes had 100% bootstrap support. 
Figure 2. One-to-one orthologs connecting H. contortus scaffolds and C. elegans chromosomes. 
Shown are (A) all 130 H. contortus scaffolds with at least five one-to-one orthologs between the two 
species, with scaffolds ordered to maximise colinearity with the C. elegans genome. (B) shows the 
relative positions of one-to-one orthologs between the two largest H. contortus scaffolds and C. 
elegans chromosomes, demonstrating the lack of conservation of gene order within syntenic blocks. 
Figure 3. Differential gene expression across the H. contortus lifecycle. (A) Numbers of genes 
significantly up-regulated (red) and down-regulated (blue) between life-stages. (B) The expression 
profiles of genes determined to be differentially expressed between any pair of stages are shown in 
clusters ordered by the stage at which they are most highly expressed. The innermost circle shows 
normalized expression levels during the egg stage with further concentric circles showing expression 
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in the L1, L3, L4 stages, followed by male worms, female worms and then female gut samples. Mean 
expression values were taken over three replicates and are shown on a log2 scale. 
Figure 4. Maximum-likelihood phylogenies of H. contortus and C. elegans ligand-gated ion channel 
families. Figure shows unrooted trees for (A) cation channel and (B) anion channel genes from the 
two nematode species, with different colours representing each major clade of channels. Within 
clades, C. elegans genes are coloured a lighter shade than H. contortus genes. Both trees show a 
general pattern of conserved one-to-one orthology, and coloured bars indicate where this pattern is 
broken – by a duplication in H. contortus (with four copies of unc-29), and by loss of some genes – 
there are four H. contortus genes (acr-26, acr-27, glc-5, glc-6) without orthologs In C. elegans, and 7 
in C. elegans missing from H. contortus (acr-13/lev-8, acr-18, acr-23, glc-1, lev-8, lgc-48, lgc-54). All 
of these genes are shown in large bold type. A truncated ortholog of C. elegans acr-9 is present in 
the H. contortus but is omitted from this phylogeny. Values near internal nodes are SH-test support 
values – with support values of 1.0 on all other nodes omitted for clarity. 
Figure 5. (A) Maximum-likelihood phylogeny of cathepsin B (cbl) genes in H. contortus and related 
nematodes. The H. contortus genome shows large, independent expansions of all three main classes 
of cbl genes: AC (anticoagulant)-like, GCP-7-like and Hmcp-like. (B) Many of the genes in two of 
these expansions occur as tandem arrays of duplicates on three scaffolds of the H. contortus 
genome. Two of these scaffolds are known to be linked, as eight of the genes occur on a previously 
completed BAC sequence. 
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